<p>The invention is concerned with novel imidazolidine derivatives of formula (I): wherein R1 to R3, A, D and E are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds bind to LXR alpha and LXR beta and can be used as medicaments.</p>
申请公布号
WO2009150109(A1)
申请公布日期
2009.12.17
申请号
WO2009EP56986
申请日期
2009.06.08
申请人
F. HOFFMANN-LA ROCHE AG;DEHMLOW, HENRIETTA;OBST SANDER, ULRIKE;SCHULZ-GASCH, TANJA;WRIGHT, MATTHEW
发明人
DEHMLOW, HENRIETTA;OBST SANDER, ULRIKE;SCHULZ-GASCH, TANJA;WRIGHT, MATTHEW
